Trending...
- City of Chicago Announces Landmark Global Settlement To Resolve Wrongful Conviction Lawsuits Tied To Ronald Watts - 109
- NEIU College of Business and Technology's bachelor's in Computer Science has been accredited by the Computing Accreditation Commission of ABET
- Riviera Marketing & MAZ6R CLAN: Tribute to the Twin Tower Tragedy!
CHICAGO, Aug. 1, 2024 ~ The Association for Diagnostics & Laboratory Medicine (ADLM) welcomed a record-breaking number of laboratory experts to their annual meeting, ADLM 2024, from July 28 to August 1. Formerly known as the AACC Annual Scientific Meeting & Clinical Lab Expo, this year's event showcased groundbreaking advancements in diagnostic research and technology, highlighting the crucial role that laboratory medicine plays in patient care.
According to ADLM, as of Thursday, August 1, over 18,000 laboratory medicine professionals had registered for the meeting. This marks a significant increase of 6% in attendance since the last time the ADLM Annual Meeting was held in Chicago in 2022. With one more day left in the meeting, even more attendees are expected to join.
One of the highlights of the event was a special session featuring representatives from ADLM, the American Medical Association, and the Children's Hospital Association. They discussed how the FDA's final rule placing laboratory developed tests under FDA oversight will have a negative impact on patient care. The session also included a caregiver and patient advocate who shared their perspective on why these tests are essential for timely diagnoses and treatment.
More on illi News
Attendees were also treated to five plenary talks led by pioneers in life sciences. In the opening plenary, Dr. Patrick Bossuyt received the prestigious Wallace H. Coulter Lectureship award and spoke about his experiences leading efforts to improve diagnostic tests. He made a compelling case for why strong clinical trials of laboratory tests are necessary.
On Monday, Dr. Kojo S.J. Elenitoba-Johnson from Memorial Sloan Kettering Cancer Center discussed how proteomic data can help healthcare professionals better understand lymphomas and develop precision oncology therapies.
Tuesday's plenary speaker was Dr. Ron H.N. van Schaik from Erasmus MC - University Medical Center Rotterdam who talked about implementing pharmacogenetics as a diagnostic tool in routine healthcare. He shared both the successes and challenges of this approach.
On Wednesday, Dr. Sharon Hillier from the University of Pittsburgh explored the development of new products for HIV prevention, including those that can be used on demand and minimize exposure to antiretroviral drugs.
The closing keynote speaker, Dr. Diana Greene Foster from the University of California, San Francisco, discussed the mental health, physical health, and socioeconomic consequences faced by individuals who are unable to get an abortion.
More on illi News
As part of ADLM's Disruptive Technology Award competition, biotech innovators presented novel technologies that could improve accurate diagnoses for more patients. The winner was Mercy BioAnalytics with their liquid biopsy platform that detects ovarian cancer in its earliest stages by measuring tumor-derived extracellular vesicles.
The ADLM 2024 Clinical Lab Expo featured nearly 900 exhibitors and covered an impressive 271,003 net square feet. This marks a 5% increase in exhibit space since the last time the meeting was held in Chicago. The expo showcased cutting-edge tests from all laboratory medicine disciplines, including artificial intelligence, molecular diagnostics, automation, point-of-care testing, mass spectrometry, mobile health, and more.
ADLM CEO Mark J. Golden expressed his excitement about the increased attendance at ADLM 2024 after the challenges faced during the COVID-19 pandemic. He also acknowledged that this has been a challenging year for laboratory medicine professionals with the FDA's final rule on laboratory developed tests. The meeting provided a crucial opportunity for attendees to learn more about what this rule means for their labs and patient care. Golden hopes that attendees will return home inspired and eager to implement what they've learned at this year's meeting in their work. He also looks forward to seeing what next year's meeting in Chicago from July 27-31 will bring.
In conclusion, ADLM 2024 was a resounding success with record-breaking attendance and groundbreaking advancements in diagnostic research and technology. The meeting provided a vital platform for laboratory medicine professionals to learn, network, and stay updated on the latest developments in their field.
According to ADLM, as of Thursday, August 1, over 18,000 laboratory medicine professionals had registered for the meeting. This marks a significant increase of 6% in attendance since the last time the ADLM Annual Meeting was held in Chicago in 2022. With one more day left in the meeting, even more attendees are expected to join.
One of the highlights of the event was a special session featuring representatives from ADLM, the American Medical Association, and the Children's Hospital Association. They discussed how the FDA's final rule placing laboratory developed tests under FDA oversight will have a negative impact on patient care. The session also included a caregiver and patient advocate who shared their perspective on why these tests are essential for timely diagnoses and treatment.
More on illi News
- Assent Unveils Extended Producer Responsibility Packaging Solution to Simplify Compliance with Expanding Packaging Laws
- KatalisCoin: "Too Secure" for Bad Actors - Platform Embraces "Excessive Compliance" Criticism
- Keyanb Exchange Implements Enhanced Security Protocols Amid Industry-Wide Trust Challenges
- TSWHZC Platform Combines Automated Portfolio Management with Proof of Reserves for Brazil Market Entry
- AureaVault Positions Digital Asset Infrastructure for Shifting Monetary Policy Environment
Attendees were also treated to five plenary talks led by pioneers in life sciences. In the opening plenary, Dr. Patrick Bossuyt received the prestigious Wallace H. Coulter Lectureship award and spoke about his experiences leading efforts to improve diagnostic tests. He made a compelling case for why strong clinical trials of laboratory tests are necessary.
On Monday, Dr. Kojo S.J. Elenitoba-Johnson from Memorial Sloan Kettering Cancer Center discussed how proteomic data can help healthcare professionals better understand lymphomas and develop precision oncology therapies.
Tuesday's plenary speaker was Dr. Ron H.N. van Schaik from Erasmus MC - University Medical Center Rotterdam who talked about implementing pharmacogenetics as a diagnostic tool in routine healthcare. He shared both the successes and challenges of this approach.
On Wednesday, Dr. Sharon Hillier from the University of Pittsburgh explored the development of new products for HIV prevention, including those that can be used on demand and minimize exposure to antiretroviral drugs.
The closing keynote speaker, Dr. Diana Greene Foster from the University of California, San Francisco, discussed the mental health, physical health, and socioeconomic consequences faced by individuals who are unable to get an abortion.
More on illi News
- JQRBT Unveils High-Speed Trading Infrastructure Designed for Growing Institutional Crypto Market
- New Leadership and Renovations Usher in Next Chapter for Sunrise Manor
- Who Will Win the 2025 WNBA Finals? OddsTrader Shares Live Betting Odds and Projections
- Naperville's Annual Public Safety Open House Set for Sept. 27
- Geeks5g Creative Marketing: The Powerhouse Behind Business Growth
As part of ADLM's Disruptive Technology Award competition, biotech innovators presented novel technologies that could improve accurate diagnoses for more patients. The winner was Mercy BioAnalytics with their liquid biopsy platform that detects ovarian cancer in its earliest stages by measuring tumor-derived extracellular vesicles.
The ADLM 2024 Clinical Lab Expo featured nearly 900 exhibitors and covered an impressive 271,003 net square feet. This marks a 5% increase in exhibit space since the last time the meeting was held in Chicago. The expo showcased cutting-edge tests from all laboratory medicine disciplines, including artificial intelligence, molecular diagnostics, automation, point-of-care testing, mass spectrometry, mobile health, and more.
ADLM CEO Mark J. Golden expressed his excitement about the increased attendance at ADLM 2024 after the challenges faced during the COVID-19 pandemic. He also acknowledged that this has been a challenging year for laboratory medicine professionals with the FDA's final rule on laboratory developed tests. The meeting provided a crucial opportunity for attendees to learn more about what this rule means for their labs and patient care. Golden hopes that attendees will return home inspired and eager to implement what they've learned at this year's meeting in their work. He also looks forward to seeing what next year's meeting in Chicago from July 27-31 will bring.
In conclusion, ADLM 2024 was a resounding success with record-breaking attendance and groundbreaking advancements in diagnostic research and technology. The meeting provided a vital platform for laboratory medicine professionals to learn, network, and stay updated on the latest developments in their field.
Filed Under: Business
0 Comments
Latest on illi News
- CELOXFI Platform Demonstrates Advanced Security Architecture and Regulatory Framework
- Work 365 Launches PV 3.0: The Keystone Power App for Microsoft CSPs
- Local consultant shows small businesses how to turn red tape into real money
- CU Aerospace DUPLEX Satellite headed to the ISS on SpaceX NG-23 Mission
- Tour Napa Like a Local: Vines of Napa Valley Wine Passport AKA Vine Pass Unlocks Hidden Gems
- Mather Goes Bold to Challenge Society's Views on Aging
- Dental Surgical Center Accepts Sedation Patients with Medicaid for MD, WV, PA and DC
- MooreSuccess Gaming Launches Digi 995: Color Protocol – A Futuristic Coloring Experience
- A New Era in Healthcare Marketing
- Chicago: Mayor Brandon Johnson Signs 'Right to Protest' Executive Order
- Sloan's Lake Dental Launches New Website to Enhance Patient Experience and Access to Modern Dental Care
- Only 3 Weeks Left till the Start of the OpenSSL Conference 2025
- InventHelp Inventor Develops Portable Sit-On-Scale (CLR-320)
- ENTOUCH Completes $50 million Funding Round
- Teaming Agreement with Emtel Energy USA to Advance Thin-Film PV Energy Storage Capabilities; NASA agreements for Solar Space Tech; Ascent Solar $ASTI
- Nebuvex Acknowledges Platform "Too Secure" for Anonymous Traders; Institutional Investors Disagree
- From Tokyo to Berlin: FreeTo.Chat Unites Cultures with the World's First Confession VRX — EmojiStream™
- AZETHIO Launches Multi-Million Dollar User Protection Initiative Following Unprecedented Platform Growth
- Matecrypt Observes South American Cryptocurrency Adoption Surge Amid Economic Shifts
- Assent Uncovers Over 695 Unique PFAS Across Global Supply Chains as Regulations Increase